AORT Artivion, Inc. Common Stock
À propos de Artivion, Inc. Common Stock Présentation de l'entreprise depuis Wikipedia
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Lire la suite
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
AORT Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
AORT Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
| Date ex-dividende | Montant |
|---|---|
| 9 décembre 2015 | $0,0300 |
| 9 septembre 2015 | $0,0300 |
| 10 juin 2015 | $0,0300 |
| 11 mars 2015 | $0,0300 |
| 10 décembre 2014 | $0,0300 |
| 10 septembre 2014 | $0,0300 |
| 11 juin 2014 | $0,0300 |
| 12 mars 2014 | $0,0280 |
| 11 décembre 2013 | $0,0280 |
| 11 septembre 2013 | $0,0280 |
| 12 juin 2013 | $0,0280 |
| 12 mars 2013 | $0,0250 |
| 12 décembre 2012 | $0,0250 |
| 12 septembre 2012 | $0,0250 |
AORT Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 5 35,7%
- Achat 8 57,1%
- Conserver 1 7,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
8 analystes · 2026-08-18Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.28 | $0.01 | -0.29% |
| 31 mars 2026 | $0.03 | $0.05 | -0.02% |
| 31 décembre 2025 | $0.05 | $0.08 | -0.03% |
| 30 septembre 2025 | $0.06 | $0.02 | 0.04% |
| 30 juin 2025 | $0.08 | $-0.00 | 0.08% |
| 31 mars 2025 | $-0.01 | $-0.12 | 0.11% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| IART | — | -1.8 | 1.5% | -31.6% | -49.6% | — |
| ASST | — | -0.1 | 1217.5% | — | — | — |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
Bilan 28
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
Compte de résultat 18
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | -88,426,000 | 47,233,000 | 44,296,000 | 42,232,000 | -83,141,000 | 41,844,000 | 41,683,000 | 41,290,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | -89,223,000 | 48,775,000 | 45,378,000 | 42,232,000 | -89,737,000 | 41,844,000 | 41,683,000 | 47,886,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
Flux de trésorerie 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $468M | $442M | · | $421M | $406M | $390M | · | $379M | $373M | $358M | · | $337M | $330M | $318M | · | $307M | |
| Net Income TTM | $-4M | $9M | · | $5M | $-4M | $3M | · | $-7M | $-8M | $-19M | · | $-40M | $-35M | $-35M | · | $-11M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -249.7 | 203.4 | · | 423.4 | -388.8 | 351.1 | · | -166.4 | -135.0 | -45.0 | · | -15.3 | -20.0 | -15.2 | · | -51.3 | |
| P/S | 2.4 | 4.1 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.9 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| P / FCF | · | -267.2 | · | · | · | -52.8 | · | · | · | · | · | · | · | -66.1 | · | · | |
| EV / EBITDA | -169.0 | 164.1 | · | 176.3 | 199.6 | 179.6 | · | 322.1 | · | · | · | -722.5 | 128.8 | 444.3 | · | -206.9 | |
| EV / FCF | · | -290.5 | · | · | · | -66.2 | · | · | · | · | · | · | · | -99.2 | · | · | |
| EV / Revenue | 3.0 | 4.5 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.7 | 3.0 | 2.6 | · | 2.8 | |
| Earnings Yield | -0.40% | 0.49% | · | 0.24% | -0.26% | 0.28% | · | -0.60% | -0.74% | -2.2% | · | -6.5% | -5.0% | -6.6% | · | -1.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $441M | $389M | $354M | $314M | $299M |
| Marge Brute % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Marge d'exploitation % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Résultat net | $10M | $-13M | $-31M | $-19M | $-15M |
| BPA dilué | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| Ratio de liquidité | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| Ratio de liquidité réduite | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $839.0K | $11M | $11M | $-14M | $-16M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 216 déclarants · $724.0M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 42 (+7 vs T. préc.) | 64 (+28 vs T. préc.) | 80 (-7 vs T. préc.) | 47 (-16 vs T. préc.) | +5.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71 566 000 | 3 184 974 | 9,88% | Actions |
| Juniper Investment Company, LLC | $45 386 816 | 2 019 885 | 6,27% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $45 043 789 | 2 004 619 | 6,22% | Actions |
| FMR LLC | $41 871 497 | 1 863 440 | 5,78% | Actions |
| STATE STREET CORP | $41 750 406 | 1 858 051 | 5,77% | Actions |
| Ophir Asset Management Pty Ltd | $40 446 180 | 1 800 008 | 5,59% | Actions |
| PERCEPTIVE ADVISORS LLC | $39 036 906 | 1 737 290 | 5,39% | Actions |
| Conestoga Capital Advisors, LLC | $36 484 539 | 1 623 700 | 5,04% | Actions |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23 011 325 | 1 024 091 | 3,18% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22 205 281 | 988 219 | 3,07% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $21 427 261 | 953 365 | 2,96% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $20 062 856 | 892 873 | 2,77% | Actions |
| CITADEL ADVISORS LLC | $17 701 821 | 787 798 | 2,44% | Actions |
| YARGER WEALTH STRATEGIES, LLC | $15 278 432 | 634 223 | 2,11% | Actions |
| ROYCE & ASSOCIATES LP | $14 364 667 | 639 282 | 1,98% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $11 702 264 | 520 795 | 1,62% | Actions |
| Qube Research & Technologies Ltd | $10 704 820 | 476 405 | 1,48% | Actions |
| FRED ALGER MANAGEMENT, LLC | $10 406 104 | 463 111 | 1,44% | Actions |
| TWO SIGMA ADVISERS, LP | $9 974 907 | 218 700 | 1,38% | Actions |
| D. E. Shaw & Co., Inc. | $9 846 714 | 438 216 | 1,36% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 183 579 | 408 704 | 1,27% | Actions |
| Toroso Investments, LLC | $9 018 146 | 197 723 | 1,25% | Actions |
| Soleus Capital Management, L.P. | $8 718 360 | 388 000 | 1,20% | Actions |
| TWO SIGMA INVESTMENTS, LP | $8 702 159 | 387 279 | 1,20% | Actions |
| Balyasny Asset Management L.P. | $8 584 686 | 382 051 | 1,19% | Actions |
| GOLDMAN SACHS GROUP INC | $7 733 095 | 344 152 | 1,07% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $6 978 103 | 310 552 | 0,96% | Actions |
| KENNEDY CAPITAL MANAGEMENT LLC | $6 611 371 | 294 231 | 0,91% | Actions |
| UBS Group AG | $6 026 544 | 268 204 | 0,83% | Actions |
| WASATCH ADVISORS LP | $5 726 929 | 156 388 | 0,79% | Actions |
| Quantinno Capital Management LP | $4 497 191 | 200 142 | 0,62% | Actions |
| AMERIPRISE FINANCIAL INC | $4 347 068 | 193 461 | 0,60% | Actions |
| FIFTH THIRD BANCORP | $4 170 912 | 185 621 | 0,58% | Actions |
| ORBIMED ADVISORS LLC | $3 932 250 | 175 000 | 0,54% | Actions |
| Corient Private Wealth LP | $3 578 618 | 159 262 | 0,49% | Actions |
| Public Sector Pension Investment Board | $3 298 304 | 146 787 | 0,46% | Actions |
| Parkman Healthcare Partners LLC | $3 121 982 | 138 940 | 0,43% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2 879 149 | 128 133 | 0,40% | Actions |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2 857 263 | 127 159 | 0,39% | Actions |
| Summit Creek Advisors LLC | $2 704 354 | 120 354 | 0,37% | Actions |
| CONNORS INVESTOR SERVICES INC | $2 700 445 | 120 180 | 0,37% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $2 693 816 | 119 885 | 0,37% | Actions |
| Bank of New York Mellon Corp | $2 522 415 | 112 257 | 0,35% | Actions |
| RHUMBLINE ADVISERS | $2 373 280 | 105 621 | 0,33% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 303 872 | 102 531 | 0,32% | Actions |
| XTX Topco Ltd | $2 173 905 | 96 747 | 0,30% | Actions |
| Swiss National Bank | $1 914 444 | 85 200 | 0,26% | Actions |
| BANK OF AMERICA CORP /DE/ | $1 912 535 | 85 115 | 0,26% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 875 420 | 51 213 | 0,26% | Actions |
| LAZARD ASSET MANAGEMENT LLC | $1 875 301 | 83 458 | 0,26% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $1 524 073 | 67 827 | 0,21% | Actions |
| ALLIANCEBERNSTEIN L.P. | $1 522 477 | 41 575 | 0,21% | Actions |
| Legal & General Group Plc | $1 468 954 | 65 374 | 0,20% | Actions |
| CITIGROUP INC | $1 425 856 | 63 456 | 0,20% | Actions |
| Squarepoint Ops LLC | $1 424 238 | 63 384 | 0,20% | Actions |
| Russell Investments Group, Ltd. | $1 303 125 | 57 994 | 0,18% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $1 193 157 | 53 100 | 0,16% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $1 117 972 | 49 754 | 0,15% | Actions |
| Sterling Capital Management LLC | $1 098 918 | 48 906 | 0,15% | Actions |
| Sio Capital Management, LLC | $1 089 368 | 48 481 | 0,15% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 010 521 | 44 972 | 0,14% | Actions |
| PRUDENTIAL FINANCIAL INC | $995 219 | 44 291 | 0,14% | Actions |
| WELLS FARGO & COMPANY/MN | $937 314 | 41 714 | 0,13% | Actions |
| VANGUARD GROUP INC | $898 699 | 19 704 | 0,12% | Actions |
| FIRST TRUST ADVISORS LP | $857 657 | 38 169 | 0,12% | Actions |
| BlackRock, Inc. | $789 461 | 35 134 | 0,11% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $738 274 | 32 856 | 0,10% | Actions |
| Verition Fund Management LLC | $729 399 | 32 461 | 0,10% | Actions |
| Aquatic Capital Management LLC | $712 771 | 31 721 | 0,10% | Actions |
| Jain Global LLC | $680 908 | 30 303 | 0,09% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $662 072 | 28 042 | 0,09% | Actions |
| Brevan Howard Capital Management LP | $652 461 | 29 037 | 0,09% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $634 193 | 28 224 | 0,09% | Actions |
| JANUS HENDERSON GROUP PLC | $623 335 | 17 038 | 0,09% | Actions |
| MetLife Investment Management, LLC | $601 050 | 26 749 | 0,08% | Actions |
| Y-Intercept (Hong Kong) Ltd | $600 735 | 26 735 | 0,08% | Actions |
| Mariner, LLC | $570 520 | 25 390 | 0,08% | Actions |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $561 750 | 25 000 | 0,08% | Actions |
| Illinois Municipal Retirement Fund | $545 010 | 24 255 | 0,08% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $516 855 | 23 002 | 0,07% | Actions |
| Walleye Capital LLC | $490 408 | 21 825 | 0,07% | Actions |
| Penn Capital Management Company, LLC | $489 689 | 21 793 | 0,07% | Actions |
| ALLSTATE CORP | $483 240 | 21 506 | 0,07% | Actions |
| EXCHANGE TRADED CONCEPTS, LLC | $476 948 | 21 226 | 0,07% | Actions |
| MORGAN STANLEY | $476 588 | 21 210 | 0,07% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $473 241 | 21 061 | 0,07% | Actions |
| Louisiana State Employees Retirement System | $420 189 | 18 700 | 0,06% | Actions |
| Invesco Ltd. | $409 628 | 18 230 | 0,06% | Actions |
| DARK FOREST CAPITAL MANAGEMENT LP | $402 123 | 17 896 | 0,06% | Actions |
| Vanguard Global Advisers, LLC | $371 384 | 16 528 | 0,05% | Actions |
| Freestone Grove Partners LP | $328 219 | 14 607 | 0,05% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $324 287 | 14 432 | 0,04% | Actions |
| JOHNSON INVESTMENT COUNSEL INC | $307 008 | 13 663 | 0,04% | Actions |
| Police & Firemen's Retirement System of New Jersey | $303 053 | 13 487 | 0,04% | Actions |
| DIKER MANAGEMENT LLC | $303 000 | 13 500 | 0,04% | Actions |
| OPPENHEIMER ASSET MANAGEMENT INC. | $284 672 | 12 669 | 0,04% | Actions |
| GUGGENHEIM CAPITAL LLC | $283 302 | 12 608 | 0,04% | Actions |
| ELEVATION POINT WEALTH PARTNERS, LLC | $263 303 | 11 718 | 0,04% | Actions |
| Vestmark Advisory Solutions, Inc. | $263 303 | 11 718 | 0,04% | Actions |
| ARIZONA STATE RETIREMENT SYSTEM | $263 101 | 11 709 | 0,04% | Actions |
Initiés de la société 49 initiés · 27 dirigeants · 15 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 6 mars 2025 M | 865 283 | 0 | 0 | $0 |
| David Ashley Lee | Executive VP, COO & CFO | 2 mars 2023 S | 347 217 | 0 | 0 | $0 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 17 juin 2025 S | 64 200 | 0 | 0 | $0 |
| John E Davis | Chief Commercial Officer | 11 mars 2025 M | 208 778 | 0 | 0 | $0 |
| Amy Horton | VP, Chief Accounting Officer | 6 mars 2025 S | 146 651 | 0 | 0 | $0 |
| Matthew A Getz | VP, Human Resources | 16 août 2024 S | 34 116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 27 février 2024 S | 21 558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 26 février 2024 S | 44 518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 23 février 2024 A | 13 291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 6 juin 2023 S | 34 724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 8 novembre 2022 A | 32 516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 12 mars 2021 F | 153 203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 14 mars 2019 F | 30 806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 14 mars 2019 F | 25 084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 5 mars 2018 F | 39 883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 16 novembre 2017 M | 77 135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 9 avril 2015 F | 1 271 846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 7 mars 2015 F | 42 106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 7 mars 2015 F | 110 559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 26 février 2015 A | 73 441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 15 août 2014 M | 95 221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 30 novembre 2012 S | 71 999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 31 décembre 2011 F | 110 144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 4 septembre 2007 A | 23 100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 18 janvier 2006 M | 42 728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 21 septembre 2004 M | 55 131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 14 septembre 2004 M | 36 165 | 0 | 0 | $0 |
| Anthony B. Semedo | Administrateur | 2 juin 2026 J | 6 325 | 0 | 0 | $0 |
| Elizabeth A Hoff | Administrateur | 22 mai 2025 A | 31 389 | 0 | 0 | $0 |
| Marna P Borgstrom | Administrateur | 22 mai 2025 A | 49 088 | 0 | 0 | $0 |
| Jon W Salveson | Administrateur | 22 mai 2025 A | 129 840 | 0 | 0 | $0 |
| Jeffrey H Burbank | Administrateur | 22 mai 2025 A | 53 796 | 0 | 0 | $0 |
| Daniel J Bevevino | Administrateur | 22 mai 2025 A | 150 061 | 0 | 0 | $0 |
| Bullock James | Administrateur | 22 mai 2025 A | 68 647 | 0 | 0 | $0 |
| Thomas F Ackerman | Administrateur | 22 mai 2025 A | 149 896 | 0 | 0 | $0 |
| Harvey Morgan | Administrateur | 30 août 2021 G | 46 342 | 0 | 0 | $0 |
| Ronald D Mccall | Administrateur | 25 août 2021 S | 121 768 | 0 | 0 | $0 |
| Elkins C Ronald | Administrateur | 5 septembre 2018 S | 64 843 | 0 | 0 | $0 |
| James Benson | Administrateur | 2 octobre 2017 S | 54 086 | 0 | 0 | $0 |
| John M Cook | Administrateur | 9 juin 2009 M | 85 000 | 0 | 0 | $0 |
| LACY VIRGINIA C | Administrateur | 24 avril 2007 S | 255 280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | Administrateur | 1 août 2006 A | 12 800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | Détenteur de 10% | 31 mai 2007 S | 1 918 000 | 0 | 0 | $0 |
| Lance A Berry | — | 14 août 2026 S | 210 112 | 0 | 1 | $-20 413 |
| Andrew M Green | — | 14 août 2026 S | 59 643 | 0 | 3 | $-928 248 |
| Jean F Holloway | — | 12 août 2026 S | 184 118 | 0 | 1 | $-27 835 |
| Michael S Simpson | — | 5 mars 2021 F | 33 698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | — | 5 mai 2020 A | 23 451 | 0 | 0 | $0 |
| Thomas J Lynch | — | 2 novembre 2004 A | 5 000 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 dépôts | 12 août 2025 | 4,00% | Amendement | — | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 11 mai 2011 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 10 juillet 2007 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 2 décembre 2005 | — | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée | 18 mars 2005 | — | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 53 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 2,95% | 5 817 NS | 30 avril 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,77% | 26 421 NS | 30 avril 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,59% | 37 075 SH | 8 août 2026 | Quotidien |
| RZG · Invesco Exchange-Traded Fund Trust | 0,44% | 22 725 SH | 8 août 2026 | Quotidien |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,25% | 21 547 NS | 31 mai 2026 | N-PORT |
| ESSC · Strategy Shares | 0,24% | 1 691 NS | 30 avril 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 0,21% | 246 008 SH | 8 août 2026 | Quotidien |
| IHI · iShares Trust | 0,16% | 202 161 SH | 8 août 2026 | Quotidien |
| IJT · iShares Trust | 0,13% | 397 869 SH | 8 août 2026 | Quotidien |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,11% | 31 285 NS | 30 avril 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,10% | 50 848 SH | 8 août 2026 | Quotidien |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,08% | 7 285 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,08% | 419 028 SH | 8 août 2026 | Quotidien |
| XJR · iShares Trust | 0,07% | 5 059 SH | 8 août 2026 | Quotidien |
| IJR · iShares Trust | 0,06% | 2 606 468 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 49 054 SH | 8 août 2026 | Quotidien |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 148 966 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,05% | 18 968 NS | 30 avril 2026 | N-PORT |
| SAA · ProShares Trust | 0,04% | 505 NS | 31 mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 158 121 NS | 30 avril 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 1 162 604 SH | 8 août 2026 | Quotidien |
| ISCG · iShares Trust | 0,04% | 14 407 SH | 8 août 2026 | Quotidien |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 28 917 SH | 8 août 2026 | Quotidien |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 14 525 NS | 31 mai 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,03% | 101 NS | 30 avril 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 263 046 SH | 8 août 2026 | Quotidien |
| SMDX · Tidal Trust III | 0,03% | 999 NS | 30 avril 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 27 103 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,02% | 2 057 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 18 392 NS | 30 avril 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 2 917 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 200 917 NS | 31 mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 2 111 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,01% | 1 609 NS | 31 mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1 624 NS | 31 mai 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,01% | 1 526 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 495 296 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 127 662 SH | 8 août 2026 | Quotidien |
| WSML · iShares Trust | 0,01% | 2 264 SH | 8 août 2026 | Quotidien |
| DFAC · Dimensional ETF Trust | 0,01% | 107 410 NS | 30 avril 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 773 NS | 31 mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 861 NS | 30 avril 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 41 NS | 31 mai 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1 937 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8 873 NS | 30 avril 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 12 377 NS | 30 avril 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 61 883 SH | 8 août 2026 | Quotidien |
| IWV · iShares Trust | 0,00% | 10 738 SH | 8 août 2026 | Quotidien |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 25 635 NS | 31 mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 636 NS | 30 avril 2026 | N-PORT |